Home » Topics » Regulatory

Regulatory
RSS

Priority review granted to Femara as first-line breast cancer therapy

Sep. 13, 2000

AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder

Sep. 13, 2000

Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program

Sep. 8, 2000

Combination approved for second-line treatment of hypertension

Sep. 8, 2000

Phase I trial of TOBI in ventilator-associated pneumonia initiated

Sep. 8, 2000

Bone Care launches Hectorol Injection

Sep. 7, 2000

Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury

Sep. 7, 2000

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...